Business Segments · Selling and administrative expense

Medical Essentials — Selling and administrative expense

Becton, Dickinson and Company Medical Essentials — Selling and administrative expense decreased by 84.7% to $185.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 83.4%, from $1.12B to $185.00M. Over 4 years (FY 2021 to FY 2026), Medical Essentials — Selling and administrative expense shows a downward trend with a -10.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ3 2013
Last reportedQ1 2026
Rolls up toSG&A

How to read this metric

An increase may signal investment in growth or market expansion, while an unexplained increase could indicate rising administrative overhead or inefficiencies.

Detailed definition

This metric represents the operating expenses incurred by the Medical Essentials segment for sales, marketing, distribut...

Peer comparison

Comparable to SG&A expenses allocated to specific business units in diversified healthcare companies.

Metric ID: bdx_segment_medical_essentials_selling_and_administrative_expense

Historical Data

24 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q3 '25Q4 '25Q4 '25Q1 '26Q1 '26
Value$1.20B$1.22B$1.19B$1.19B$1.15B$1.18B$1.19B$1.21B$1.19B$1.14B$1.21B$1.19B$1.20B$1.26B$1.32B$165.00M$1.12B$164.00M$1.32B$1.52B$1.39B$180.00M$1.21B$185.00M
QoQ Change+1.8%-3.0%+0.6%-3.6%+3.0%+0.3%+1.5%-1.2%-4.5%+6.7%-1.6%+0.3%+4.9%+5.0%-87.5%+577.0%-85.3%+704.9%+15.4%-8.5%-87.1%+573.9%-84.7%
YoY Change-4.3%-3.2%+0.2%+1.1%+3.6%-3.9%+2.2%-1.0%+0.5%+10.4%+8.7%-86.4%-6.4%-86.3%+10.4%+21.4%+5.7%-86.3%+8.6%-83.4%
Range$164.00M$1.52B
CAGR-27.8%
Avg YoY Growth-14.4%
Median YoY Growth+0.3%

Frequently Asked Questions

What is Becton, Dickinson and Company's medical essentials — selling and administrative expense?
Becton, Dickinson and Company (BDX) reported medical essentials — selling and administrative expense of $185.00M in Q1 2026.
How has Becton, Dickinson and Company's medical essentials — selling and administrative expense changed year-over-year?
Becton, Dickinson and Company's medical essentials — selling and administrative expense decreased by 83.4% year-over-year, from $1.12B to $185.00M.
What is the long-term trend for Becton, Dickinson and Company's medical essentials — selling and administrative expense?
Over 4 years (2021 to 2026), Becton, Dickinson and Company's medical essentials — selling and administrative expense has grown at a -10.9% compound annual growth rate (CAGR), from $4.72B to $2.97B.
What does medical essentials — selling and administrative expense mean?
The total operating costs for selling and administrative functions within the Medical Essentials segment.